Bluebird Ventures
Overview
Bluebird Ventures is a venture capital firm that creates and invests in life sciences companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Prima Mente | Jun 2023 | Seed | Co-investor |
| Kriya Therapeutics | May 2022 | Series C | Co-investor |
| Epirium Bio | Dec 2019 | Series A | Co-investor |
| Nutcracker Therapeutics | Mar 2022 | Series C | Co-investor |
| Procyrion | Feb 2024 | Series E | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Bluebird Ventures based?
Bluebird Ventures is headquartered in Palo Alto, California, United States.
When was Bluebird Ventures founded?
Bluebird Ventures was founded in 2019.
How many portfolio companies does Bluebird Ventures have?
Bluebird Ventures has 8 portfolio companies in Caplight's dataset.
What are some companies in Bluebird Ventures's portfolio?
Portfolio companies visible on Caplight include Prima Mente, Kriya Therapeutics, Epirium Bio, Nutcracker Therapeutics, Procyrion.
What was Bluebird Ventures's most recent investment shown here?
Bluebird Ventures's most recent investment in this portfolio sample was in Procyrion in 2024.
What sectors does Bluebird Ventures focus on?
Bluebird Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does Bluebird Ventures focus on?
Bluebird Ventures typically invests at the Mid stage.
What is Bluebird Ventures's AUM?
Bluebird Ventures's assets under management are estimated between $129.0M and $138.0M.